Performant Healthcare Inc PHLT.OQ PHLT.O is expected to show a rise in quarterly revenue when it reports results on March 12 for the period ending December 31 2024
The Pleasanton California-based company is expected to report a 4.9% increase in revenue to $34.147 million from $32.57 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Performant Healthcare Inc is for a loss of 2 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Performant Healthcare Inc is $7.00, above its last closing price of $2.77.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | -0.03 | -0.03 | -0.03 | Met | 0 |
Jun. 30 2024 | -0.05 | -0.05 | -0.04 | Beat | 20 |
Mar. 31 2024 | -0.06 | -0.06 | -0.05 | Beat | 23.1 |
Dec. 31 2023 | 0.01 | 0.02 | Beat | 300 | |
Sep. 30 2023 | -0.03 | -0.02 | -0.01 | Beat | 60 |
Jun. 30 2023 | -0.04 | -0.04 | -0.05 | Missed | -11.1 |
Mar. 31 2023 | -0.06 | -0.06 | -0.06 | Met | 0 |
Dec. 31 2022 | -0.02 | 0.00 | Beat | 100 |
This summary was machine generated March 10 at 20:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments